Ignite Creation Date:
2024-05-06 @ 4:47 PM
Last Modification Date:
2024-10-26 @ 2:16 PM
Study NCT ID:
NCT05095636
Status:
UNKNOWN
Last Update Posted:
2021-10-27
First Post:
2021-10-02
Brief Title:
Apatinib Monotherapy Versus Apatinib Combined With Camrelizumab for Third-line Treatment of Metastatic Gastric Cancer
Sponsor:
Organization:
Fudan University